Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.17 USD | -0.54% | -3.68% | -18.42% |
Apr. 12 | Sector Update: Health Care Stocks Lower Friday Afternoon | MT |
Apr. 12 | Theravance Biopharma Shares Rise After BTIG Starts Coverage at Buy | MT |
Business Summary
Number of employees: 99
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Human Therapeutics
100.0
%
| 51 | 100.0 % | 57 | 100.0 % | +11.84% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
99.6
%
| 51 | 99.6 % | 57 | 99.6 % | +11.89% |
Europe
0.4
%
| 0 | 0.4 % | 0 | 0.4 % | +0.45% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Rick Winningham
CEO | Chief Executive Officer | 64 | 13-06-30 |
Aziz Sawaf
DFI | Director of Finance/CFO | 42 | 14-05-31 |
Stuart Knight
CTO | Chief Tech/Sci/R&D Officer | - | 14-10-31 |
Richard Graham
CTO | Chief Tech/Sci/R&D Officer | - | - |
Rhonda Farnum
CTO | Chief Tech/Sci/R&D Officer | 59 | 18-06-30 |
Aine Miller
PRN | Corporate Officer/Principal | 47 | - |
Stacy Pryce
PRN | Corporate Officer/Principal | - | - |
Brett Grimaud
LAW | General Counsel | 50 | 21-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Dean Mitchell
BRD | Director/Board Member | 68 | 14-05-31 |
Eran Broshy
BRD | Director/Board Member | 65 | 14-06-01 |
Burt Malkiel
BRD | Director/Board Member | 90 | 13-09-30 |
Director/Board Member | 59 | 20-06-30 | |
Susannah Gray
BRD | Director/Board Member | 63 | 23-02-25 |
Rick Winningham
CEO | Chief Executive Officer | 64 | 13-06-30 |
Jim Kelly
BRD | Director/Board Member | 43 | 23-04-10 |
Donal O'Connor
BRD | Director/Board Member | 73 | 15-10-20 |
Laurie Alsup
BRD | Director/Board Member | 70 | 18-02-12 |
Jeremy Grant
BRD | Director/Board Member | 36 | Dec. 20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 48,559,955 | 41,512,139 ( 85.49 %) | 0 | 85.49 % |
Company contact information
Theravance Biopharma, Inc.
901 Gateway Boulevard
94080, South San
+650 808 6000
http://www.theravance.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.42% | 445M | |
+25.61% | 660B | |
+25.87% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+7.09% | 219B | |
-9.12% | 196B | |
+5.01% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- TBPH Stock
- Company Theravance Biopharma, Inc.